05:25 AM EDT, 04/28/2026 (MT Newswires) -- Prolight Diagnostics (PRLD.ST) secured a second patent in Japan for its Psyros single-molecule-counting technology, according to a Tuesday release.

The Japan Patent Office issued the notification on April 24, adding swab tests for infectious diseases under the scope of the technology.

Ämnen i artikeln

Prolight Diagnostics

Senast

14,26

1 dag %

1,13%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån